Recombinant Preferentially Expressed Antigen In Melanoma (PRAME)

Verified reactivity

Homo sapiens (Human)
Protein number

P78395
Gene number

Please refer to GenBank
Other name

MAPE; OIP4; CT130; Cancer/Testis Antigen 130; Opa-interacting protein 4; Melanoma antigen preferentially expressed in tumors
Protein origin

E.coli
Protein region

Please contact us.
Protein sequence

Please contact us.
Information about sequence

Asn416~Leu502
Expected molecular weight

11.4kDa
Protein purity

≥ 92%
Verified applications

SDS-PAGE; WB; ELISA; IP.
Storage recommendation

Aliquot and store at -20°C. Minimize freezing and thawing.
Use before

1 year
Shipping requirements

Blue ice
Estimated production time

7-11 business days
Notes

For research use only. Not for diagnostic procedures.
Hyperlink
Description

Antigens are peptides or recombinant or native dependent on the production method.
Source

Recombinants or rec. proteins
Group

recombinants

Gene target

Preferentially Expressed Melanoma PRAME
Gene symbol

PRAME
Short name

Recombinant Preferentially Expressed Antigen In Melanoma (PRAME)
Technique

Recombinant, antigen, antigenes, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. bioma advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
Label

N-terminal His-Tag
Alternative name

Rec. Preferentially Expressed protein In Melanoma (preferentially expressed antigen in melanoma)
Alternative technique

rec, antigenes
Alternative to gene target

preferentially expressed antigen in melanoma, CT130 and MAPE and OIP-4 and OIP4, PRAME and IDBG-2240 and ENSG00000185686 and 23532, retinoic acid receptor binding, nuclei

Name

Mammary Neoplasms, Experimental
Concept

Scope note: Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.
Tree numbers
- C04.588.531.500
- C04.619.590
- E05.598.500.496.843
Qualifiers

diagnosis, parasitology, immunology, microbiology, diagnostic imaging, physiopathology, secondary, enzymology, etiology, mortality, epidemiology, blood, cerebrospinal fluid, chemically induced, congenital, diet therapy, drug therapy, therapy, chemistry, psychology, urine, virology, history, blood supply, classification, economics, embryology, genetics, nursing, radiotherapy, prevention & control, pathology, ultrastructure, metabolism, complications, surgery